Based on these findings, future research should elucidate whether the stroke‐induced signaling through IL‐1β and NLRP3 inflammasome pathway could potentially trigger and exacerbate disturbances in the glucose metabolism in ischemic stroke patients. Here, NLRP3 is linked to stroke disorder.